Internal Medicine, Hematology & Oncology · Houston, TX
NPI
1104089036
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6445 Main St, Opc Floor 24
Houston, TX, 77030
Phone (713) 441-2813
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
511 services
Medicare patients, 2024
168
Average age 72
Drug cost, 2024
$3.2M
840 prescriptions
Company payments, 2025
$38K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sai Ravi Kiran Pingali was code 99214 (office e&m - established), 153 times for 81 patients. In total Sai Ravi Kiran Pingali billed 511 services in 14 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 153 | 81 | $98.50 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 151 | 47 | $94.56 | $14K |
| 99213 Office E&M - Established | Office | 86 | 60 | $57.16 | $4,915 |
| 99215 Office E&M - Established | Office | 43 | 29 | $141.53 | $6,086 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 11 | $62.86 | $1,194 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $138.04 | $2,347 |
| 99205 Office E&M - New | Office | 16 | 16 | $177.24 | $2,836 |
By year: 2022 $73K for 828 services; 2023 $51K for 597 services; 2024 $49K for 511 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sai Ravi Kiran Pingali prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 105 prescriptions and refills. In total Sai Ravi Kiran Pingali wrote 840 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 105 | 195 | 47 | $5,752 |
| Prednisone Generic | 58 | 58 | 19 | $195 |
| Ondansetron Odt Ondansetron | 49 | 49 | 32 | $413 |
| Fluconazole Generic | 35 | 43 | 17 | $1,101 |
| Revlimid Lenalidomide | 30 | 30 | Under 11 | $551K |
| Tramadol Hcl Generic | 27 | 27 | Under 11 | $152 |
| Levofloxacin Generic | 24 | 26 | 15 | $94.32 |
| Brukinsa Zanubrutinib | 22 | 22 | Under 11 | $315K |
| Dexamethasone Generic | 21 | 21 | 11 | $270 |
| Cyclosporine Modified Cyclosporine, Modified | 20 | 36 | Under 11 | $4,300 |
| Lenalidomide Generic | 20 | 20 | Under 11 | $350K |
| Cefpodoxime Proxetil Generic | 20 | 20 | Under 11 | $2,895 |
| Doxycycline Hyclate Generic | 17 | 17 | Under 11 | $121 |
| Jakafi Ruxolitinib Phosphate | 16 | 16 | Under 11 | $245K |
| Bosulif Bosutinib | 15 | 15 | Under 11 | $157K |
Brand drugs: 162 claims; generic drugs: 678 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sai Ravi Kiran Pingali $38K ($12K in general payments such as food, travel and fees and $26K for research) from 7 companies. The largest payer was Acrotech Biopharma Inc. with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.